Table 2.
Baseline values of participants’ oxidative stress, inflammatory biomarkers and quality of life among the four groups (n = 81).
| Sociodemographic and Clinical Data | AEW Group (n = 20), Mean (SD) |
Walking Group (n = 20), Mean (SD) |
AEW and Walking Group (n = 20), Mean (SD) |
Control Group (n = 21), Mean (SD) |
p Value (F) a |
|---|---|---|---|---|---|
| AOPPs (ng/ml) | 0.38 (0.57) | 0.35 (0.43) | 0.53 (0.70) | 0.44 (0.65) | 0.794 (0.343) |
| AGEs (ng/L) | 0.35 (0.54) | 0.27 (0.32) | 0.46 (0.59) | 0.39 (0.58) | 0.715 (0.454) |
| MDA (nmol/ml) | 0.77 (0.42) | 0.85 (0.69) | 0.97 (0.67) | 0.96 (0.62) | 0.691 (0.489) |
| FBG (mg/dl) | 298.95 (48.84) | 303.95 (67.95) | 324.60 (59.63) | 287.24 (80.43) | 0.331 (1.159) |
| WBCs (103/µL) | 7.92 (0.51) | 8.19 (0.44) | 8.48 (0.93) | 8.19 (1.16) | 0.199 (1.589) |
| NLR | 2.63 (0.22) | 2.55 (0.18) | 2.61 (0.22) | 2.62 (0.23) | 0.691 (0.488) |
| SF36-PCS | 45.16 (6.34) | 45.16 (6.34) | 44.94 (6.82) | 43.99 (5.75) | 0.922 (0.161) |
| SF36-MCS | 46.52 (8.12) | 47.50 (9.01) | 46.43 (6.67) | 46.66 (8.99) | 0.976 (0.070) |
| SF36-Total QoL | 45.84 (6.22) | 46.33 (6.63) | 45.69 (4.64) | 45.33 (5.20) | 0.955 (0.107) |
Note—n: number, SD: standard deviation, AEW: alkaline electrolyzed water, AOPPs: advanced oxidation protein products, AGEs: advanced glycation end products, MDA: malondialdehyde, FBG: fasting blood glucose, WBCs: white blood cells, NLR: neutrophil-lymphocyte ratio, SF-36: Short Form 36, PCS: Physical component score, MCS: mental component score, QoL: quality of life. a Analysis of variance, with the F-value in the bracket behind p-value of <0.01.